| Ten-year all-cause mortality in hospitalized non-surgical patients based on nutritional status screening V Kissova, J Rosenberger, M Goboova, A Kiss Public Health Nutrition 18 (14), 2609-2614, 2015 | 11 | 2015 |
| The impact of therapeutic drug monitoring (TDM) in optimizing dosage regimens of gentamicin in patients with augmented renal clearance M Goboova, M Kuzelova, T Fazekas, V Kissova, V Kakosova, L Salkovska International Journal of Clinical Pharmacy 38 (2), 596-596, 2016 | 8 | 2016 |
| An adjustment of vancomycin dosing regimen for a young patient with augmented renal clearance: A case report/Úprava dávkového režimu vankomycínu pre mladého pacienta so … M Goboova, M Kuzelova, V Kissova, D Bodakova, E Martisova European Pharmaceutical Journal 62 (2), 1-4, 2015 | 5 | 2015 |
| The problem of low peak concentration of gentamicin in clinical practice M Göböová, M Kuželová, T Foltánová European Pharmaceutical Journal 59 (Supplement-VI), 35-43, 2012 | 3 | 2012 |
| Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults E Puchon, M Goboova, I Vano, T Fazekas, Z Javorova-Rihova, ... European Geriatric Medicine 11, 1051-1061, 2020 | 2 | 2020 |
| Drug induced rhabdomyolysis: Spontaneous case reports V Kakosova, R Riedel, D Buzassyova, R Kamenska, M Goboova International Journal of Clinical Pharmacy 37 (1), 279-279, 2015 | 1 | 2015 |
| Ascorbic acid intake during pregnancy. K Podolska, D Mazankova, M Goboova, I Vano Biomedical Papers of the Medical Faculty of Palacky University in Olomouc …, 2023 | | 2023 |
| Retrospective Assessment of the Use of Pharmacotherapeutic Agents in Pregnancy with Potential Impact on Neonatal Health K Podolská, D Mazánková, M Göböová European Pharmaceutical Journal 69 (2), 17-25, 2022 | | 2022 |
| Overview of daily-contact substances having a possible embryotoxic and fetotoxic effect in pregnancy when patient being chronically exposed or overdosed K Podolská, D Mazánková, M Göböová | | 2022 |
| Vzťah expozície tehotných žien liečivám CNS so zameraním sa na antidepresíva ku klinickým výstupom tehotenstva K Podolská, D Mazánková, M Göböová | | 2021 |
| Comparison of the newest available criteria for dosing of non-vitamin K antagonist oral anticoagulants in older patients with atrial fibrillation E Puchon, M Goboova, I Vano, M Kuzelova INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 42 (1), 278-278, 2020 | | 2020 |
| Important role of clinical pharmacist in optimizing dosage regimens of gentamicin at the beginning of therapy M Goboova, E Puchon, I Vano, M Kuzelova INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 42 (1), 265-266, 2020 | | 2020 |
| Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy? M Göböová, I Vaňo, V Kissová, T Fazekaš, M Kuželová European Pharmaceutical Journal 66 (1), 11-18, 2019 | | 2019 |
| Terapeutické monitorovanie hladín ako súčasť optimalizácie dávkovacích režimov gentamicínu u pacientov so zmenenou farmakokinetikou M Göböová, V Kissová, M Kuželová Klinická farmakologie a farmacie 28 (2), 55-58, 2014 | | 2014 |
| Is safety monitoring of retinoids for the systemic treatment of acne in clinical practice sufficient? V Kakosova, R Kamenska, T Magalova, T Foltanova, M Goboova INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 35 (6), 1345-1345, 2013 | | 2013 |
| Is gentamicin administered to overweight or obese patients and to patients with augmented renal clearance in the optimal dose regimens? M Goboova, M Kuzelova, L Salkovska, V Kakosova INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 35 (5), 882-882, 2013 | | 2013 |
| The significance of the clinical pharmacist in management of gentamicin dosage regimens according to TDM and pharmacokinetic parameters M Goboova, M Kuzelova, V Kakosova INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 34 (1), 148-149, 2012 | | 2012 |
| Klinicka farmacia na Slovensku na prahu noveho tisicrocia L Magulova, M Goboova, V Kakosova FARMACEUTICKY OBZOR 70 (7/8), 185-186, 2001 | | 2001 |
| THE ROLE OF MATERNAL NUTRITION DURING PREGNANCY–OVERVIEW OF DAILY DOSAGES RECOMMENDATIONS K Podolská, D Mazánková, M Göböová, I Vaňo FOLIA, 100, 0 | | |
| Optimalizácia dávkovacích režimov gentamicínu u špecifických skupín pacientov a informácie o lieku M Göböová, M Kuželová | | |
Tomáš FazekašComenius University in BratislavaOverená e-mailová adresa na: fpharm.uniba.sk
